1. HOME

Biosimilars

Brand Name Image INN Therapeutic Areas More information
NameRemsima®
Infliximab
INNInfliximab
IndicationsRheumatology, Gastroenterology, Dermatology
Approved By EMA(EU) Medicines.ie
NameRemsima® SC
Infliximab
INNInfliximab
IndicationsRheumatology, Gastroenterology, Dermatology
Approved By EMA(EU) Medicines.ie
NameTruxima®
Rituximab
INNRituximab
IndicationsOncology, Rheumatology
Approved By EMA(EU) Medicines.ie
NameHerzuma®
Trastuzumab
INNTrastuzumab
IndicationsOncology
Approved By EMA(EU) Medicines.ie
NameYuflyma®▼
Adalimumab
INNAdalimumab
IndicationsRheumatology, Gastroenterology, Dermatology
Approved By EMA(EU) Medicines.ie
NameVegzelma®▼
Bevacizumab
INNBevacizumab
IndicationsOncology
Approved By EMA(EU) Medicines.ie
NameSteqeyma®▼
Ustekinumab
INNUstekinumab
IndicationsRheumatology, Gastroenterology, Dermatology
Approved By EMA(EU) Medicines.ie


This product description is for medical and educational purposes only and not intended to promote the product. For more details, please consult a doctor, nurse or pharmacist.

▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly to HPRA Pharmacovigilance via www.hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine.

INN, international non-proprietary name

Novel Therapeutics

Brand Name Image INN Therapeutic Areas More information


This product description is for medical and educational purposes only and not intended to promote the product. For more details, please consult a doctor, nurse or pharmacist.

▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly to HPRA Pharmacovigilance via www.hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine.

INN, international non-proprietary name

popup
You are leaving CelltrionHealthcare Ireland.

The Celltrion Healthcare Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals and other products or uses of those products that are not approved in other countries or regions. If you are a resident of a country other than those to which the site is directed, please contact your local Celltrion Healthcare affiliate to obtain the appropriate product information for your country of residence.

The Celltrion Healthcare site that you have requested may be in a language that differs from your country of origin. The Celltrion Healthcare site that you have requested may not be optimized for your screen size.

Do you wish to leave this site?

We collect cookies

We use cookies to provide the services and features offered on our site and to improve the experience of our users. Cookies are data that are downloaded or stored on your computer or other device.

PRIVACY POLICY
▶ Essential cookies
Always Active

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms.

▶ Analytics cookies

Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.